US2017246145A1PendingUtilityA1
Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections
Est. expiryFeb 12, 2023(expired)· nominal 20-yr term from priority
A61P 31/20A61P 31/12A61P 31/14A61P 35/00A61K 45/06A61K 31/365A61K 31/366A61K 31/335C07D 493/18A61K 31/357A61K 2300/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In certain aspects, the invention relates to methods of treating proliferative cervical disorders (such as cervical cancer and cervical dysplasia) and treating virus infection by administering artemisinin-related compounds. In certain aspects, the invention relates to methods of treating a tumor induced by an oncogenic virus, methods of killing or inhibiting a squamous cell carcinoma, and methods of inhibiting the replication of a virus, by administering artemisinin-related compounds.
Claims
exact text as granted — not AI-modified1 . A method of treating an individual suffering from a virus infection, comprising administering to the individual a therapeutically effective amount of an artemisinin-related compound.
2 .- 54 . (canceled)Join the waitlist — get patent alerts
Track US2017246145A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.